Cancer Research Targets EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, X.-Y.
Right arrow Articles by Wang, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, X.-Y.
Right arrow Articles by Wang, Y.
[Cancer Research 62, 1598-1603, March 15, 2002]
© 2002 American Association for Cancer Research

Advances in Brief

An ATM-independent S-Phase Checkpoint Response Involves CHK1 Pathway1

Xiang-Yang Zhou, Xiang Wang, Baocheng Hu, Jun Guan, George Iliakis and Ya Wang2

Department of Radiation Oncology, Kimmel Cancer Center of Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107


   ABSTRACT
Top
 ABSTRACT
Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 
After exposure to genotoxic stress, proliferating cells actively slow downthe DNA replication through a S-phase checkpoint to provide time for repair. We report that in addition to the ataxia-telangiectasia mutated (ATM)-dependent pathway that controls the fast response, there is an ATM-independent pathway that controls the slow response to regulate the S-phase checkpoint after ionizing radiation in mammalian cells. The slow response of S-phase checkpoint, which is resistant to wortmannin, sensitive to caffeine and UCN-01, and related to cyclin-dependent kinase phosphorylation, is much stronger in CHK1 overexpressed cells, and it could be abolished by Chk1 antisense oligonucleotides. These results provide evidence that the ATM-independent slow response of S-phase checkpoint involves CHK1 pathway.


   Introduction
Top
 ABSTRACT
 Introduction
Materials and Methods
 Results
 Discussion
 REFERENCES
 
In response to DNA damage, eukaryotic cells activate a set of surveillance systems that interrupt cell cycle progression to allow time for repair. These surveillance systems are called checkpoints and have been given an empirical definition. The DNA damage checkpoint acts in three stages in the cell cycle, one at the G1-S phase transition (G1 checkpoint), one at S phase (S-phase checkpoint), and one at the G2-M boundary (G2 checkpoint; Ref. 1 ). With checkpoint failure, the immediate consequence is that the cells increase their sensitivity to being killed, and the long-term consequence is that the cells increase their susceptibility to tumor genesis. S-phase checkpoint monitors progression through S phase, which slows the rate of on-going DNA synthesis (2, 3, 4, 5) . Although the genetic requirements for the S-phase checkpoint have been investigated in detail in yeast (6) , the mechanism in mammalian cells is still unclear. The ATM gene is mutated in the autosomal recessive disease AT.3 Cells from the AT patients show defects in cell cycle checkpoints (including G1, S-phase, and G2 checkpoints) and hypersensitivity to DNA DSB inducers such as IR. One hallmark of the AT cells is that they show less inhibition of DNA synthesis immediately after IR when compared with the wild-type cells (7 , 8) . Until now, the ATM-dependent pathway that includes CHK2, Nijmegen breakage syndrome and BRCA1 (the downstream targets of ATM) was considered to be the only major S-phase checkpoint regulator in mammalian cells after IR (9, 10, 11, 12, 13) . However, as we report here, AT cells do show increasing inhibition as time passes and reach a maximum inhibition at ~3 h after IR, although they have less inhibition of DNA synthesis immediately (about 5 min) after IR. At 3 h after IR, there is little difference in the rates of DNA synthesis between AT cells and wild-type cells. These observations suggest that, besides ATM, another ATM-independent pathway also regulates the S-phase checkpoint after DNA damage. After systematically characterizing the S-phase checkpoint, we found that the IR-induced response of S-phase checkpoint could be divided into two processes: the fast (from several minutes to ~2 h) and the slow (1.0 h to 6 h. After 6 h there was no testing). The ATM-dependent pathway controls only the fast response of S-phase checkpoint; the slow response is controlled by an ATM-independent pathway. The data shown in this report suggest that this ATM-independent pathway involves CHK1. The ATM-dependent and ATM-independent pathways cooperate together to maintain the intact S-phase checkpoint in mammalian cells after IR.


   Materials and Methods
Top
 ABSTRACT
 Introduction
 Materials and Methods
Results
 Discussion
 REFERENCES
 
Cell Culture.
Human primary fibroblasts, ATM mutant AT5BI (kindly provided by Dr. Malcolm Paterson, MRC Reproductive Biology Unit, Edinburgh, United Kingdom.) and wild-type WI38 (kindly provided by Dr. Paul Philips, Drexel-Medical College of Pennsylvania Hahnemann) cells were grown in MEM containing 10% fetal bovine serum. Human transformed fibroblasts, ATM mutant AT5BIVA (Camden Depository), and wild-type MRC5SV1 (kindly provided by Dr. Colin Arlett, Medical Research Council Cell Mutation Unit and Center for Medical Research, University of Sussex, Brighton, United Kingdom); rat transformed embryo fibroblasts, A1–5 and B4 cells (kindly provided by Dr. Arnold J. Levine, Department of Molecular Biology, Princeton University, Princeton, NJ) were grown in DMEM containing 10% bovine calf serum. Human transformed lymphoblasts, ATM mutant AT5ABR, and wild-type C3ABR cells (kindly provided by Dr. Martin F. Lavin, The Queensland Cancer Fund Research Laboratory, Brisbane, Queensland, Australia) were grown in RPMI 1640 containing 10% bovine calf serum.

DNA Synthesis, Chemicals, and Irradiation.
The measurement of DNA synthesis was similar to that described previously (14) . Briefly, 1 x 105 fibroblasts (AT5BI, WI38, AT5BIVA, MRC5SV1, A1–5, and B4 cells) or 3 x 105 of lymphoblasts (AT5ABR and C3ABR cells) from a growing culture were seeded in 60-mm tissue-culture dishes with 3 ml of medium and allowed to grow for more than one doubling time. Fibroblasts were prelabeled with medium containing 10 nCi of [14C]thymidine and 0.5 µM cold thymidine. This prelabeling provides an internal control for cell number by allowing normalization for total DNA content of samples. The suspension-growing lymphoblasts were partially taken from a sample for counting before they were loaded onto the microfiber filters.

Before irradiation, the lymphoblast cultures were directly added with the chemicals, and fibroblast cells were replaced with prewarmed medium (washed off [14C]thymidine) containing either caffeine, wortmannin, and UCN-01, or wortmannin plus UCN-01 for 30 min. After the cells were exposed to X-rays (310 kV, 10 mA, 2-mm aluminum filter) at room temperature, they were returned to 37°C. The chemicals were kept in the culture until cells were harvested. [3H]thymidine at 1 µCi was added for 15 min at different times thereafter. The cells were then collected. The following procedures as described previously (14) were used. The rate of DNA synthesis for each sample was calculated as 3H dpm/14C dpm (fibroblasts) or 3H dpm/cell number (lymphoblasts) and is presented as a percentage of the control values obtained from sham-irradiated cells at the same time point.

Alkaline Sucrose Gradient Sedimentation.
As described previously (15) , this method was used to determine the molecular weight distribution of newly synthesized DNA in the irradiated cells. Linear sucrose gradients (5–20%) were prepared in a buffer containing 0.1 M NaOH, 0.9 M NaCl, and 10 mM EDTA (pH 12.5) in polyallomer tubes. AT and the wild-type cells were irradiated and returned to 37°C for 3 h; then [3H]thymidine at 5 µCi/ml was added to the culture for 15 min. The following procedures were carried out as described previously (15) .

Flow Cytometry Measurement.
As described previously (16) , cells were collected at different times, and fixed in 70% ethanol. Cells were stained with the solution (62 µg/ml RNase A, 40 µg/ml propidium iodide, and 0.1% Triton X-100 in PBS buffer) at room temperature for 1 h. The distribution of cells in the cell cycle was measured in a flow cytometer (Coulter Epics Elite).

Treatment of Cells with Antisense Oligonucleotides.
Among human, rat, and mouse, the start codon region of Chk1 mRNA is conserved but that of Chk2 is varied. Therefore, the antisense oligonucleotide of rat Chk1 (5'-GGCACTGCCATGACTCCA-3'), designed to specifically target the sequence of the start codon region of rat Chk1 mRNA (16) , was used to inhibit CHK1 expression in human cells. And the rat Chk2 antisense oligonucleotide (5'-TGACTCTTCATATCCGAC-3': Ref. 16 ), was used as the control oligonucleotide in human cells. The oligonucleotides were delivered to cells by OligofectAMINE (Life Technologies, Inc.) according to the manufacturer’s instructions. Briefly, antisense oligonucleotides (1.0 µM for AT5BIVA and MRC5SV1 cells, 1.5 µM for A1–5 and B4 cells) were added to serum-free MEM containing 20 µl/ml OligofectAMINE reagent. This preparation (1 ml) was added to 30% confluent cells cultured in 60-mm plate (prelabeled with 10 nCi [14C]thymidine for 24 h) for 4.5 h. Additional DMEM (0.5 ml) with 30% iron-supplemented calf serum was then added to the culture for another 14 h. The cells were either prepared to measure the inhibition of DNA synthesis 3 h after IR, as described above, or were directly collected in 1x protein loading buffer [50 mM Tris-Cl (pH 6.8), 100 mM DTT, 2% SDS, 0.1% bromphenol blue, and 10% glycerol] and prepared for Western blot.

Immunopreciptation and Western Blotting.
Whole cell extracts were prepared as described previously (16) . Four hundred µg were mixed with 1.5 µg of CDK2 antibody (sc-163; Santa Cruz Biotechnology, Inc.) in the presence of 20 µl of a 50% (v/v) protein A-Sepharose slurry (Life Technologies, Inc.) in 400 µl of buffer (0.5% NP40, 1 mM Na3VO4, 5 mM NaF, 0.2 mM phenylmethylsulfonyl fluoride in PBS buffer) and gently rotated overnight at 4°C. Immune complexes were washed three times with the same buffer, boiled in protein loading buffer and then separated in 12% SDS-PAGE gel. For the antisense oligonucleotide experiments, the treated cells were collected, directly lysed in 1x protein gel-loading buffer and separated in 10% SDS-PAGE gel. Antibodies of PCNA (sc-56), CHK1 (sc-8408) and CHK2 (sc-9064) were purchased from Santa Cruz Biotechnology, Inc.; antibody of p21WAF1/Cip1 was purchased from Lab Vision Corporation; antibody of phospho-CDK2 (Tyr-15) was purchased from Cell Signaling Technology; and antibody of GAPDH was purchased from Chemicon International.


   Results
Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
Discussion
 REFERENCES
 
A Slow Response of S-Phase Checkpoint Exists in Both AT and Wild-Type Mammalian Cells.
DNA damage-induced S-phase checkpoint represents the inhibition of DNA synthesis and is measured as a transit decrease in [3H]thymidine incorporation (7 , 13) . In previous observations, we found that the inhibition of DNA synthesis in mammalian cells showed increasing inhibition as time passed after IR (14) , the strongest inhibition usually occurred at ~3 h after IR. To test whether ATM is involved in the time-dependent inhibition of DNA synthesis, we examined the inhibition of DNA synthesis in AT cells at different times after IR. Fig. 1ACitation shows the dose response of DNA synthesis in AT cells and their wild-type counterpart at 0.5 h or 3 h after IR. Although AT cells showed less inhibition of DNA synthesis at 0.5 h after IR compared with the wild-type cells (Fig. 1ACitation , solid and dotted lines only), which is similar to previous reports by other investigators (7 , 8 , 12) , AT cells did show a strong inhibition of DNA synthesis at 3 h after IR (Fig. 1ACitation , solid lines and symbols), which results in little difference from the wild-type cells. The time-kinetic results of DNA synthesis in AT cells and their wild-type counterpart after IR (Fig. 1B)Citation further confirmed that the strong inhibition of DNA synthesis occurred in AT primary fibroblasts (Fig. 1BCitation , AT5BI), AT transformed fibroblasts (Fig. 1BCitation , AT5BIVA), and AT transformed lymphoblasts (Fig. 1BCitation , AT5ABR) at a later time after IR. We propose to name the inhibition of DNA synthesis that occurred immediately (at several min after IR) "the fast response of S-phase checkpoint," and to name the inhibition that occurred late (the maxim at ~3 h after IR) "the slow response of S checkpoint." The result of the fast response lacking in AT cells indicates that ATM is involved. The result of the slow response found in AT cells suggests that an ATM-independent pathway controls it.



View larger version (35K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 1. A slow response of S-phase checkpoint is shown in both AT cells and wild-type cells. A, dose-response curves for the rate of DNA synthesis at 0.5 h (solid line only, AT cells; dotted line only, wild-type cells) and 3 h (lines and symbols) after IR. B, kinetics of the rate of DNA synthesis as a function of postirradiation incubation time. The dose of radiation was 30 Gy for the fibroblasts and 20 Gy for the lymphoblasts. The rate of DNA synthesis for each sample was calculated as 3H dpm/14C dpm (3H dpm/cell number for lymphoblasts) and was presented as a percentage of the control values obtained from sham-irradiated cells at the same time point. Data shown are the averages from three independent experiments.

 
The Slow Response of S-Phase Checkpoint Affects Replicon Initiation and Is an Active, Independent Process.
The DNA synthesis could be inhibited by the checkpoint regulation either at replicon initiation or at chain elongation. The ATM-dependent S-phase checkpoint is mainly involved in replicon initiation (7) . To examine which component of the DNA synthesis is involved in the ATM-independent slow response of S-phase checkpoint, we carried out the gradient experiments. The results (Fig. 2A)Citation showed that the newly synthesized DNA in AT cells was strongly inhibited at 3 h after IR, which is similar to the time interval observed in wild-type cells, although the newly synthesized DNA was less inhibited in AT cells immediately after IR when compared with that observed in the wild-type cells (data not shown). These results indicate that the ATM-independent slow S-phase checkpoint also mainly affects the replicon initiation.



View larger version (31K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 2. The slow response of S-phase checkpoint is also involved in the replicon initiation but is a different process from the fast response of the S-phase checkpoint. A, alkaline sedimentation profiles of nascent DNA from AT5BIVA and MRC5SV1 cells either sham-irradiated ({bullet}) or exposed to 30 Gy X-rays ({circ}) and returned to 37°C for 3 h before analysis. Plotted is the percentage of 3H activity as a function of fraction number. Shown in the figure for comparison are also the sedimentation distances of T2 (167 kb) and T7 (37 kb) phage DNA. B, the effect of the drugs on radiation-induced inhibition of DNA synthesis in transformed fibroblasts. Similar to Fig. 1Citation , before irradiation, cells were added with 3 mM caffeine ({bullet}), or 20 µM wortmannin ({circ}), or UCN-01 ({blacktriangledown}, 100 nM), or 20 µM wortmannin plus UCN-01 ({triangledown}) or without drug (····) for 30 min. Then cells were exposed to X-rays (30 Gy) and returned to 37°C. The drugs were kept in the culture until cells were harvested. Data shown are the averages from three independent experiments. C, the effect of the drugs on the percentage of S-phase cells in transformed lymphoblasts at different times after 20 Gy irradiation analyzed by flow cytometry. The cells were treated with 3 mM caffeine ({bullet}), or 20 µM wortmannin ({circ}), or 100 nM UCN-01 ({triangledown}) as described in "Material and Methods." ····, data from non-drug-treated samples.

 
To further characterize the slow response of S-phase checkpoint, we examined the effects of inhibitors (caffeine, wortmannin, or UCN-01) of different kinases on the rates of DNA synthesis at different times after IR (Fig. 2B)Citation . Wortmannin, which, at 20 µM, inhibits the phosphoinositide-3 kinase family that includes ATM and DNA-PK but not Ataxia and Rad3 related, did not affect the slow response of S-phase checkpoint in AT cells (Fig. 2BCitation , AT5BIVA, 3-h point), which indicates that DNA-PK is not involved in the slow response. Wortmannin, on the other hand, mainly inhibited the fast response of S-phase checkpoint in ATM normal cells (Fig. 2BCitation , MRC5SV1, reversed the inhibition of DNA synthesis at 0.25 h) and in DNA-PK-deficient cells, MO59J (data not shown), which resulted in the AT-like phenotypes in these cells. These results suggest that DNA-PK is not involved in the fast response either. Caffeine, which at 3 mM inhibits ATM and ATR kinases (17) , completely inhibited both the fast and the slow responses of S-phase checkpoint in AT and the wild-type cells (Fig. 2BCitation , AT5BIVA and MRC5SV1, reversed the inhibition of DNA synthesis). This result suggests that the target of caffeine in AT cells that controls the slow response might be ATR. The UCN-01 data (Fig. 2B)Citation support this hypothesis. UCN-01, which at 100 nM could efficiently inhibit CHK1 (18 , 19) [the ATR downstream substrate (20) ], but did not affect CHK2 (18 , 19) [the ATM downstream substrate (21, 22, 23) ], mainly inhibited the slow response in both AT and wild-type cells (Fig. 2BCitation , after 3 h). Moreover, when wortmannin and UCN-01 were administered together, they induced the caffeine-like effects that deleted both the fast and the slow responses of S-phase checkpoint (Fig. 2BCitation , MRC5SV1). Similar results were also observed in the transformed lymphoblasts, AT5ABR and C3ABR (data not shown in Fig. 2BCitation ).

By analyzing the effects of the inhibitors on the S-phase checkpoint, we could clearly separate the slow response of the S-phase checkpoint pathway from the fast one. Although both the fast and the slow responses were sensitive to caffeine, the fast one was sensitive to wortmannin and resistant to UCN-01, whereas the slow one was sensitive to UCN-01 and resistant to wortmannin. These results strongly suggest that the fast response of S-phase checkpoint is controlled mainly by the ATM pathway, which is sensitive to caffeine and wortmannin, and the slow response is mainly controlled by an ATM-independent pathway, which is sensitive to caffeine and UCN-01.

To determine that the slow response of S-phase checkpoint, as well as the effects of the inhibitors reflected an active response of the cells rather than a reduction in the S-phase fraction, we measured the cell cycle distribution at different times after IR by a flow cytometry. Fig. 2CCitation shows the ratio of the cells in S-phase. The percent of cells in S-phase gradually increased both in AT (AT5ABR) and in its wild-type counterpart (C3ABR) after IR (Fig. 2C)Citation , indicating that the reduced [3H]thymidine incorporation in irradiated cells is derived from a slowdown of DNA synthesis. In addition, caffeine and UCN-01, but not wortmannin, abolished the increase in the percentage of S-phase cells in both AT5ABR and C3ABR cells at 3 h after IR (Fig. 2C)Citation , which was consistent with the data of [3H]thymidine incorporation (Fig. 1BCitation , AT5ABR and C3ABR, other data not shown).

The Slow Response of S-Phase Checkpoint Involves CHK1 Pathway.
To further test the hypothesis that the slow response of S-phase checkpoint might be involved in the CHK1 pathway, we examined the slow S-phase checkpoint response in the cells in which CHK1 was either over- or down-expressed.

A1–5 and B4 are a pair of transformed rat embryo fibroblasts derived from the same genetic background (24) , but only A1–5 cells showed much higher CHK1 expression (16) . We compared the rates of DNA synthesis in irradiated A1–5 and B4 cells. Similar to the other mammalian cells tested in our laboratory, this pair of cells also showed a time-dependent S-phase checkpoint response (Fig. 3A)Citation . As we expected, A1–5 cells with overexpression of CHK1 showed much more inhibition of DNA synthesis at 3 h after IR compared with B4 cells, although there was not much difference in the inhibition between the two cell lines at short intervals after IR (Fig. 3ACitation , 15 min and 1 h after IR). The stronger slow response of S-phase checkpoint (inhibition of DNA synthesis observed at 3 h after IR) in A1–5 cells was reduced by caffeine and UCN-01 but was not affected by wortmannin (Fig. 3B)Citation . These results provide additional information that CHK1 might be involved in the slow response of S-phase checkpoint.



View larger version (32K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 3. CHK1 is involved in the slow response of S-phase checkpoint. A, kinetics of the rate of DNA synthesis as a function of postirradiation incubation time in A1–5 ({bullet}) and B4 ({circ}) cells. The dose of radiation is 20 Gy. As indicated in Fig. 1Citation , the rate of DNA synthesis for each sample was calculated as 3H dpm/14C dpm and is presented as a percentage of the control values obtained from sham-irradiated cells at the same time point. B, the effect of the indicated inhibitors on the slow S-phase checkpoint in irradiated A1–5 and B4 cells. The A1–5 ({bullet}) and B4 ({circ}) cells were treated with the inhibitors of kinases (3 mM caffeine, or 20 µM wortmannin, or 100 nM UCN-01) as indicated in Fig. 2Citation . The rates of DNA synthesis were measured at 3 h after different doses of IR. C, the protein levels of CHK1 and GAPDH (as the internal standard) were analyzed by Western blotting after the antisense oligonucleotides treatment. Cells were collected and directly lysed in 1x protein gel-loading buffer. D, the effect of Chk1 antisense oligonucleotide on the slow S-phase checkpoint. The treatment with the designed antisense and irradiation were as described in "Materials and Methods." The three sets of data are from AT5BIVA (group 1), MRC5SV1 (group 2), and A1–5 cells (group 3) treated with the OligofectAMINE reagent alone or combined with Chk1 or with control oligonucleotide. The data shown in A, B, and D, mean values and SDs from three independent experiments.

 
To confirm that the stronger slow response of S-phase checkpoint in A1–5 cells was because of the higher expression of CHK1, we examined the effects of underexpressed CHK1 on the rate of DNA synthesis at 3 h after IR in A1–5 cells by designed Chk1 antisense oligonucleotide. As we reported previously (16) , Chk1 antisense oligonucleotide specifically reduced CHK1 expression in A1–5 cells. We show here that Chk1 antisense oligonucleotide released the inhibition of DNA synthesis significantly at 3 h after IR in A1–5 cells (Fig. 3DCitation , no. 3). Although Chk2 antisense oligonucleotide reduced CHK2 expression (16) , it did not affect the inhibition of DNA synthesis at the same time (Fig. 3DCitation , no. 3). Because the sequence of the 18 bp around CHK1 start code, which we chose to design the antisense, is the same among mouse, rat, and human, we used this antisense to treat human cells. CHK1 protein levels were reduced in antisense oligonucleotide-treated AT cells and their wild-type counterparts (Fig. 3C)Citation . Under such conditions, Chk1 antisense oligonucleotide released the inhibition of DNA synthesis significantly at 3 h after IR in both AT5BIVA and MRC5SV1 cells (Fig. 3DCitation , nos. 1 and 2). At the same time, as an ideal control, rat Chk2 antisense oligonucleotide did not change CHK1 protein levels (Fig. 3CCitation , oligo) and did not affect the inhibition of DNA synthesis (Fig. 3DCitation , nos. 1 and 2). These results give direct evidence that the slow response of S-phase checkpoint involves the CHK1 pathway.

We have previously reported that, in addition to ATM kinase, there is another ATM-independent kinase that controls the S-phase checkpoint in camptothecin-treated cells (25) . By using the antisense oligonucleotide, we observed that Chk1 antisense oligonucleotide could release the inhibition of DNA synthesis in camptothecin-treated AT cells (data not shown), which suggests that the ATM-independent regulation in camptothecin-treated cells is related to CHK1 pathway.

The Slow Response of S-Phase Checkpoint Involves Inactivation of CDK2.
CDK2 is highly activated and plays an important role during S phase (26) . Recently it was reported that the inhibitory phosphorylation of CDK2 on Tyr-15 is involved in the S-phase checkpoint response regulated by the ATM-dependent pathway (11) . We investigated further whether the inactivation of CDK2 was also involved in the slow response of the S-phase checkpoint. Because the antibody of Tyr-15-phosphorylated protein binds to both the phosphorylated forms of CDK2 and CDC2, and to observe only the phosphorylation of CDK2, we used this antibody to directly react to the total CDK2 immunoprecipitated from the whole cell lysates with CDK2 antibody.

The protein levels of total CDK2 did not change in both AT (AT5ABR and AT5BIVA) and their counterpart (MRC5SV1 and C3ABR) cells (Fig. 4)Citation . However, the phosphorylation of CDK2 on Tyr-15 became much stronger after IR (Fig. 4)Citation . The levels of CDK2 phosphorylation in AT5ABR cells gradually increased and reached a maximum at 3 h after irradiation (Fig. 4A)Citation and maintained high levels of phosphorylation for up to 6 h (data after 3 h not shown). On the other hand, the phosphorylation of CDK2 in C3ABR cells increased to a maximum level immediately after irradiation (Fig. 4A)Citation and maintained high levels for up to 6 h (data after 3 h not shown). Either caffeine or UCN-01 significantly inhibited IR-induced phosphorylation levels of CDK2 in both AT5ABR and C3ABR cells at 1 h, 3 h (Fig. 4A)Citation , and 6 h (data not shown) after irradiation. However, wortmannin inhibited IR-induced phosphorylation levels of CDK2 only in C3ABR cells at 1 h after irradiation and had no significant effects on the phosphorylation levels of CDK2 at 3 (Fig. 4A)Citation or 6 h (data not shown) in both AT5ABR and C3ABR cells after irradiation. Furthermore, CHK1 antisense oligonucleotide significantly reduced the phosphorylation of CDK2 in both AT5BIVA and MRC5SV1 cells 3 h after IR (Fig. 4B)Citation . Compared with Chk1 antisense, the control oligonucleotide had less effect on the phosphorylation of CDK2 at the same time (Fig. 4B)Citation . These results combined with the DNA synthesis data shown in Figs. 1Citation 2Citation 3Citation suggest that the inhibitory phosphorylation of CDK2 is related to both the fast and the slow responses of S-phase checkpoint.



View larger version (45K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 4. Phosphorylation of CDK2 is involved in both the fast and the slow responses of S-phase checkpoint. A, the effects of caffeine, UCN-01, and wortmannin on the phosphorylation of CDK2 in AT5BR (AT) and C3ABR (C3) cells. Drug treatment and irradiation are the same as in Fig. 2Citation . Immunoblotting with antibodies of CDK2 and Tyr-15 phosphorylated CDK2 (CDK2-p) was applied to either whole cell extracts (WCE) or to CDK2 antibody immunoprecipitated (IP) proteins. h, time after IR. B, the effects of Chk1 antisense oligonucleotide on the phosphorylation of CDK2 in AT5BIVA and MRC5SV1 cells 3 h after IR. Antisense treatment and irradiation are the same as in Fig. 3Citation , described in "Materials and Methods." The levels of CDK2 phosphorylation (CDK2-p) and total protein (CDK2) were analyzed by Western blotting.

 

   Discussion
Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
REFERENCES
 
The molecular mechanisms controlling DNA damage checkpoints have important implications for both cancer genesis and cancer therapy. However, less is known about S-phase checkpoint regulation than about G1 and G2 checkpoint regulations. Our results indicate that there is a time-dependent inhibition of DNA synthesis in IR-irradiated AT and wild-type cells. This IR-induced time-dependent inhibition of DNA synthesis was also observed in all of the proliferating mammalian cell lines that we tested (including human and murine, normal and tumor cell lines, data not shown). Our results demonstrate that the time-dependent inhibition of DNA synthesis is regulated by two independent but cooperating pathways: one is the ATM-dependent pathway, which controls mainly the fast response of S-phase checkpoint; the other is an ATM-independent pathway, which controls mainly the slow response of S-phase checkpoint and may use the ATR/CHK1-dependent pathway. We believe that these two pathways are used universally to control IR-induced S-phase checkpoints in mammalian cells. On the basis of the data of AT5BIVA and MRC5SV1 cells shown in Fig. 2BCitation , we could draw a graph to describe the fast and the slow S-phase checkpoint responses (Fig. 5)Citation . We should point out here that because the time and level for the fast or slow response of S-phase checkpoints are dependent on cell type, there is no universal definition for the period and intensity of the fast or slow response of S-phase checkpoints.



View larger version (18K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 5. A model is explained for the fast and slow responses of S-phase checkpoint pathways. The graph is based on the data obtained from Fig. 2BCitation . F, the fast response; S, the slow response. The fast response of S-phase checkpoint starts immediately after IR and reaches the maximal level at ~0.5 h, then goes down until it vanishes at ~3 h after IR. The slow response of S-phase checkpoint starts at ~1 h after IR, gradually increases and reaches the maximal level at ~3 h, then goes down. The ATM-dependent pathway regulates the fast response of the S-phase checkpoint and an ATR/CHK1-dependent pathway regulates the slow response of the S-phase checkpoint.

 
The ATM-dependent fast response of S-phase checkpoint is thought to primarily represent an inhibition of replicon initiation (7) . Our results show that the newly synthesized DNA is also strongly inhibited in AT and wild-type cells 3 h after irradiation. On the basis of these results plus our previous observation (15) , which showed that the strong inhibition of replicon initiation in transformed rat embryo fibroblast cell line 3.7, at 3 h after IR, could be mainly reversed by staurosporine (one derivation of UCN-01), the nonspecific CHK1 inhibitor, we believe that the ATM-independent and CHK1-involved slow response of S-phase checkpoint also mainly affects the replicon initiation. A new publication (27) , which reported that CHK1 plays a role in an intra-S-phase checkpoint controlling late-origin firing, confirms our findings.

After DNA damage, both ATM and ATR pathways are activated and, in turn, activate their downstream substrates CHK2 and CHK1, respectively (4) . The activation of CHK2 and CHK1 then lead to inactivation of their downstream substrate CDC25, the phosphatase. Therefore, CDC25 could not remove the inhibitory phosphorylation of CDK2 on Tyr-15, which prevents the activation of this kinase (28 , 29) . Our data show that both fast and slow responses of the S-phase checkpoint involve the inhibitory phosphorylation of CDK2. This model is shown in Fig. 5Citation . The family of CDC25 phosphatase has three members: CDC25A, CDC25B, and CDC25C. Although it has been reported that the CDC25A level is significantly reduced after IR in wild-type cells but not reduced in AT cells (11) , we did not find any apparent changes of CDC25A levels in either AT or wild-type cells with the antibody (sc-97; Santa Cruz Biotechnology, Inc.) used in our experiments at different times after IR with different doses (data not shown). More studies are needed to explain the controversial results. One possible explanation is that CDC25A may have different isoforms and only one of them degrades in a ubiquitous manner after IR, as described previously (11) . At this moment, we still do not know which member of the CDC25 family plays a role in the inactivation of CDK2 during the slow response of the S-phase checkpoint.

It has been reported that, in response to DNA damage, p21WAF1/Cip1 could inhibit DNA replication through direct binding to CDK2 and through association with PCNA (30) . Although p21WAF1/Cip1 with PCNA increased as time passed after IR in both AT and the wild-type cells (data not shown), the changes in drug-treated cells in our experiments did not match the DNA synthesis data, which suggests that the p21WAF1/Cip1 with PCNA did not directly relate to the slow response of the S-phase checkpoint.

The fact that the fast and slow S-phase-checkpoint pathways respond to DNA damage at different times suggests that they are activated through different structures of DNA. DNA DSBs induced by IR (31 , 32) could immediately activate the ATM pathway. In general, DNA DSBs are repaired within 2 h by nonhomologous end joining (33) . During the repair time, either the rejoined but still not normal structure of DNA, or the ATM-induced replication blocks, or both of them, may in turn activate the ATR pathway and continue to promote the process of homologous recombination repair. As time passes after DNA damage, the slow S-phase checkpoint pathway may gradually take over the role of the fast S-phase checkpoint pathway. In this way, the two pathways could cooperate with each other to control the S-phase checkpoint and to maintain genetic integrity in mammalian cells.


   ACKNOWLEDGMENTS
 
We thank Drs. Malcolm Paterson, Paul Philips, Colin Arlett, Martin F. Lavin, and Arnold J. Levine for the cell lines. We thank Nancy Mott for help in the preparation of the manuscript.


   FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by NIH Grants CA76203, CA56706, T32-CA09137, and P30-CA56036, and a grant from RTOG. Back

2 To whom requests for reprints should be addressed, at Thomas Jefferson University, Department of Radiation Oncology, Thompson Building B-13, 1020 Sansom Street, Philadelphia, PA 19107. Phone: (215) 955-2045; Fax: (215) 955-2052; E-mail: ya.wang{at}mail.tju.edu Back

3 The abbreviations used are: AT, ataxia telangiectasia; DSB, double-strand break; IR, ionizing radiation; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; PCNA, proliferating cell nuclear antigen; DNA-PK, DNA-dependent protein kinase; ATM, ataxia-telangiectasia mutated; CDK, cyclin-dependent kinase. Back

Received 9/28/01. Accepted 1/22/02.


   REFERENCES
Top
 ABSTRACT
 Introduction
 Materials and Methods
 Results
 Discussion
 REFERENCES
 

  1. Paulovich A. G., Toczyski D. P., Hartwell L. H. When checkpoints fail. Cell, 88: 315-321, 1997.[Medline]
  2. Paulovich A. G., Hartwell L. H. A checkpoint regulates the rate of progression through S phase in S. cerivisiae in response to DNA damage. Cell, 82: 841-847, 1995.[Medline]
  3. Weinert T. DNA damage checkpoints update: getting molecular. Curr. Opin. Gen. Dev., 8: 185-193, 1998.[Medline]
  4. Zhou B-B. S., Elledge S. J. The DNA damage response: putting checkpoints in perspective. Nature (Lond.), 408: 433-439, 2000.[Medline]
  5. Limoli C. L., Giedzinski E., Morgan W. F., Cleaver J. E. Polymerase {eta} deficiency in the xeroderma pigmentosum variant uncovers an overlap between the S phase checkpoint and double-strand break repair. Proc. Natl. Acad. Sci. USA, 97: 7939-7946, 2000.[Abstract/Free Full Text]
  6. Rhind N., Russell P. Mitotic DNA damage and replication checkpoints in yeast. Curr. Opin. Cell Biol., 10: 749-758, 1998.[Medline]
  7. Painter R. B., Young B. R. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc. Natl. Acad. Sci. USA, 77: 7315-7317, 1980.[Abstract/Free Full Text]
  8. Houldsworth J., Lavin M. F. Effect of ionizing radiation on DNA synthesis in ataxia telangiectasia cells. Nucleic Acids Res., 8: 3709-3720, 1980.[Abstract/Free Full Text]
  9. Petrini J. H. The Mre11 complex and ATM: collaborating to navigate S phase. Curr. Opin. Cell Biol., 12: 293-296, 2000.[Medline]
  10. Kastan M. B., Lim D-S. The many substrates and functions of ATM. Nat. Rev. Mol. Cell Biol., 1: 179-186, 2000.[Medline]
  11. Falck J., Mailand N., Syljuasen R. G., Bartek J., Lukas J. The ATM-CHK2-CDC25A checkpoint pathway guards against radioresistant DNA synthesis. Nature (Lond.), 410: 842-847, 2001.[Medline]
  12. Lim D-S., Kim S-T., Xu B., Maser R. S., Lin J., Petrini J. H. J., Kastan M. B. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature (Lond.), 404: 613-617, 2000.[Medline]
  13. Xu B., Kim S-t., Kastan M. B. Involvement of Brca1 in S-phase and G2-phase checkpoints after ionizing irradiation. Mol. Cell. Biol., 21: 3445-3450, 2001.[Abstract/Free Full Text]
  14. Wang Y., Iliakis G. Prolonged inhibition by x-rays of DNA synthesis in cells obtained by transformation of primary rat embryo fibroblasts with oncogenes H-ras and v-myc. Cancer Res., 52: 508-514, 1992.[Abstract/Free Full Text]
  15. Wang Y., Cheong N., Iliakis G. Persistent inhibition of DNA synthesis in irradiated rat embryo fibroblasts expressing the oncogenes H-ras plus v-myc derives from inhibition of replicon initiation and is mitigated by staurosporine. Cancer Res., 53: 1213-1217, 1993.[Abstract/Free Full Text]
  16. Hu B., Zhou X. Y., Wang X., Zeng Z. C., Iliakis G., Wang Y. The radioresistance to killing of A1–5 cells derives from activation of the CHK1 pathway. J. Biol. Chem., 276: 17693-17698, 2001.[Abstract/Free Full Text]
  17. Sarkaria J. N., Busby E. C., Tibbetts R. S., Roos P., Taya Y., Karnitz L. M., Abraham R. T. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res., 59: 4375-4382, 1999.[Abstract/Free Full Text]
  18. Graves P. R., Yu L., Schwarz J. K., Gales J., Sausville E. A., O’Connor P. M., Piwnica-Worms H. The CHK1 protein kinase and the CDC25C regulatory pathways are targets of the anticancer agent UCN-01. J. Biol. Chem., 275: 5600-5605, 2000.[Abstract/Free Full Text]
  19. Busby E. C., Leistritz D. F., Abraham R. T., Karnitz L. M., Sarkaria J. N. The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hCHK1. Cancer Res., 60: 2108-2112, 2000.[Abstract/Free Full Text]
  20. Liu Q., Guntuku S., Cui X. S., Matsuoka S., Cortez D., Tamai K., Luo G., Carattini-Rivera S., DeMayo F., Bradley A., Donehower L. A., Elledge S. J. CHK1 is an essential kinase that is regulated by Atr and required for the G2/M DNA damage checkpoint. Genes Dev., 14: 1448-1459, 2000.[Abstract/Free Full Text]
  21. Matsuoka S., Huang M., Elledge S. J. Linkage of ATM to cell cycle regulation by the CHK2 protein kinase. Science (Wash. DC), 282: 1893-1897, 1998.[Abstract/Free Full Text]
  22. Brown A. L., Lee C. H., Schwarz J. K., Mitiku N., Piwnica-Worms H., Chung J. H. A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. Proc. Natl. Acad. Sci. USA, 96: 3745-3750, 1999.[Abstract/Free Full Text]
  23. Chaturvedi P., Eng W. K., Zhu Y., Mattern M. R., Mishra R., Hurle M. R., Zhang X., Annan R. S., Lu Q., Faucette L. F., Scott G. F., Li X., Carr S. A., Johnson R. K., Winkler J. D., Zhou B-B. S. Mammalian CHK2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene, 18: 4047-4054, 1999.[Medline]
  24. Martinez J., Georgoff I., Martinez J., Levine A. J. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev., 5: 151-159, 1991.[Abstract/Free Full Text]
  25. Zhou X-Y., Wang Y. Inhibition of DNA replication in camptothecin-treated cells is regulated by protein kinases. Ann. N. Y. Acad. Sci., 922: 355-359, 2000.[Medline]
  26. Fotedar R., Fotedar A. Cell cycle control of DNA replication. Prog. Cell Cycle Res., 1: 73-89, 1995.[Medline]
  27. Feijoo C., Hall-Jackson C., Wu R. K., Jenkins D., Leitch J., Gilbert D. M., Smythe C. Activation of mammalian CHK1 during DNA replication arrest: a role for CHK1 in the intra-S phase checkpoint monitoring replication origin firing. J. Cell Biochem., 154: 913-923, 2001.
  28. Poon R. Y. C., Jiang W., Toyoshima H., Hunter T. Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage. J. Biol. Chem., 271: 13283-13291, 1996.[Abstract/Free Full Text]
  29. Mailand N., Falck J., Lukas C., Syljuasen R. G., Welcker M., Bartek J., Lukas J. Rapid destruction of human CDC25A in response to DNA damage. Science (Wash. DC), 288: 1425-1429, 2000.[Abstract/Free Full Text]
  30. Dotto G. P. p21WAF1/Cip1: more than a break to the cell cycle?. Biochim. Biophys. Acta, 1471: M43-M56, 2000.[Medline]
  31. Smith G. C. M., Cary R. B., Lakin N. D., Hann B. C., Teo S-H., Chen D. J., Jackson S. P. Purification, and DNA binding properties of the ataxia-telangiectasia gene product ATM. Proc. Natl. Acad. Sci. USA, 96: 11134-11139, 1999.[Abstract/Free Full Text]
  32. Suzuki K., Kodama S., Watanabe M. Recruitment of ATM protein to double strand DNA irradiated with ionizing radiation. J. Biol. Chem., 274: 25571-25575, 1999.[Abstract/Free Full Text]
  33. Jeggo P. A. DNA breakage and repair. Adv. Genet., 38: 186-218, 1998.



This article has been cited by other articles:


Home page
 Molecular Cancer TherapeuticsHome page
S. Ray, S. Shyam, G. C. Fraizer, and A. Almasan
S-phase checkpoints regulate Apo2 ligand/TRAIL and CPT-11-induced apoptosis of prostate cancer cells
Mol. Cancer Ther., April 1, 2007; 6(4): 1368 - 1378.
[Abstract] [Full Text] [PDF]

Home page
 Radiat Prot DosimetryHome page
P. Jeggo and M. Lobrich
Radiation-induced DNA damage responses
Radiat Prot Dosimetry, December 1, 2006; 122(1-4): 124 - 127.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. K. Schwartz and M. A. Shah
Targeting the Cell Cycle: A New Approach to Cancer Therapy
J. Clin. Oncol., December 20, 2005; 23(36): 9408 - 9421.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Hu, H. Wang, X. Wang, H.-R. Lu, C. Huang, S. N. Powell, K. Huebner, and Y. Wang
Fhit and CHK1 Have Opposing Effects on Homologous Recombination Repair
Cancer Res., October 1, 2005; 65(19): 8613 - 8616.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Wang, H. Wang, S. N. Powell, G. Iliakis, and Y. Wang
ATR Affecting Cell Radiosensitivity Is Dependent on Homologous Recombination Repair but Independent of Nonhomologous End Joining
Cancer Res., October 1, 2004; 64(19): 7139 - 7143.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Wang, T. Wiltshire, Y. Wang, C. Mikell, J. Burks, C. Cunningham, E. S. Van Laar, S. J. Waters, E. Reed, and W. Wang
ATM-dependent CHK2 Activation Induced by Anticancer Agent, Irofulven
J. Biol. Chem., September 17, 2004; 279(38): 39584 - 39592.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. Caporali, S. Falcinelli, G. Starace, M. T. Russo, E. Bonmassar, J. Jiricny, and S. D'Atri
DNA Damage Induced by Temozolomide Signals to both ATM and ATR: Role of the Mismatch Repair System
Mol. Pharmacol., September 1, 2004; 66(3): 478 - 491.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
X. Wang, J. Guan, B. Hu, R. S. Weiss, G. Iliakis, and Y. Wang
Involvement of Hus1 in the chain elongation step of DNA replication after exposure to camptothecin or ionizing radiation
Nucleic Acids Res., February 3, 2004; 32(2): 767 - 775.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Wang, J. Khadpe, B. Hu, G. Iliakis, and Y. Wang
An Overactivated ATR/CHK1 Pathway Is Responsible for the Prolonged G2 Accumulation in Irradiated AT Cells
J. Biol. Chem., August 15, 2003; 278(33): 30869 - 30874.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Xiao, Z. Chen, A. H. Gunasekera, T. J. Sowin, S. H. Rosenberg, S. Fesik, and H. Zhang
Chk1 Mediates S and G2 Arrests through Cdc25A Degradation in Response to DNA-damaging Agents
J. Biol. Chem., June 6, 2003; 278(24): 21767 - 21773.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
R. S. Weiss, P. Leder, and C. Vaziri
Critical Role for Mouse Hus1 in an S-Phase DNA Damage Cell Cycle Checkpoint
Mol. Cell. Biol., February 1, 2003; 23(3): 791 - 803.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
E. Okubo, J. M. Lehman, and T. D. Friedrich
Negative Regulation of Mitotic Promoting Factor by the Checkpoint Kinase Chk1 in Simian Virus 40 Lytic Infection
J. Virol., December 20, 2002; 77(2): 1257 - 1267.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Wang, G. C. Li, G. Iliakis, and Y. Wang
Ku Affects the CHK1-dependent G2 Checkpoint after Ionizing Radiation
Cancer Res., November 1, 2002; 62(21): 6031 - 6034.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, X.-Y.
Right arrow Articles by Wang, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, X.-Y.
Right arrow Articles by Wang, Y.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online